Abnormalities in
Eye Movements and Attention Can Predict Risk of Schizophrenia
|
"What was very exciting for us is that this
method allows you to assign a probability to every person in the
sample with respect to likelihood of risk for schizophrenia
liability. By doing this, one can generate very precise
estimates of where individuals fall on the risk dimension"
|
(February 21, 2007) -- A Binghamton University researcher has established a new framework to
help determine whether individuals might be
at risk for schizophrenia.
In a study published in this month's Journal of Abnormal Psychology,
Mark F. Lenzenweger, a professor of clinical science, neuroscience and
cognitive psychology at Binghamton University, State University of New York
(SUNY), is the first to have found that abnormalities in eye movements and
attention can be used to divide people into two groups in relation to
schizophrenia-related risk.
"Schizophrenia affects one in every 100 people,¨ said Lenzenweger, who
considers it the costliest form of
mental illness known to humankind. It has
a strong genetic component; about 80 percent of what determines
schizophrenia is related to genetic influences.
"Not only does it impair people's cognitive, emotional, social and
occupational functioning when it's going in full symptomatic form" he said,
"it stays with people across the lifespan.
Schizophrenia starts early in
life, beginning anywhere from 15 to 30, and continues onward. What you have
is a person who is impaired, has been removed from the workforce, as well as
requires lifelong care and there are immense costs attached to their
illness.¨
According to Lezenweger, prior studies started with someone who had the
illness and then backtracked to find deficits, such as eye tracking and
sustained attention problems.
"What I said we needed to do was to go into the general population and
measure those traits - those neurocognitive processes - and see whether
impairment in those processes predicts schizotypic features. So I really
turned the whole question on its head" said Lezenweger.
The study, funded by a $100,000 Distinguished Investigator Award from the
National Alliance for Research on Schizophrenia and Depression, or NARSAD,
involved 300 adults drawn from the general population. The findings suggests
that the manner in which the eyes can follow a target and how well one can
pay attention to a task together help to pinpoint risk factors related to
schizophrenia.
"I was able to integrate several threads of work that I had been
developing over the prior 15 or 20 years" he said. "I proposed the study in
a way that tied together several methodological and theoretical threads in
the way I would want to do it ideally, and they supported it. It was a
high-risk funding decision, and I am grateful to NARSAD for getting behind
the study"
Lenzenweger collaborated with Geoff McLachlan at the University of
Queensland in Australia and Donald B. Rubin of Harvard University, both
leaders in the application of new statistical methods to health-related
problems. They applied a technique called finite mixture modeling to
separate the research subjects into the two groups.
For years, debate in the field has centered on whether risk for
schizophrenia was graded or more binary in nature. Lenzenweger and his
colleagues showed that people could be divided into two groups, those at
risk and those not at risk.
In the new study, the smaller of the two groups contained individuals who
displayed dilute forms of schizophrenia-like symptoms even though they had
never had the illness. Study of these people revealed actual schizophrenia
in their biological family members, but not other psychiatric illnesses.
"What was very exciting for us is that this method allows you to assign a
probability to every person in the sample with respect to likelihood of risk
for schizophrenia liability" Lenzenweger said. "By doing this, one can
generate very precise estimates of where individuals fall on the risk
dimension"
A second, mathematically independent model called taxometric analysis
generated the same clean partitioning of the two groups, Lenzenweger noted.
Although the risk predictions can be made now, they are not yet
ready for clinical applications by practicing therapists. Lenzenweger
envisions using the new model as a way to choose schizotypic individuals -
people who are at risk for the illness but do not have it- for more
intense genomic study. That sort of research may help scientists pinpoint
the gene or genes that cause schizophrenia.
"The study of schizotypic individuals offers a unique perspective on what
might cause the illness" Lenzenweger explained. "It provides a clearer
window on the likely underpinnings of the illness prior to the devastating
impact of the clinical illness.
By: Binghamton University
Source: RxPG
Last updated: 02/07
top ~
news table of contents ~
send page to a
friend
|